Tocolytic Agents Market
Number of pages: 100 | Report Format: PDF | Published date: May 04, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
CAGR |
5.3% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Drug Class, Route of Administration, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global tocolytic agents market is expected to grow at a revenue CAGR of 5.3% from 2023 to 2031.
Tocolytic Agents Market Fundamentals
Tocolytic agents are a class of medications that are used to prevent or treat premature labor or preterm delivery. Premature labor is defined as the onset of regular uterine contractions before the 37th week of gestation, which can lead to preterm delivery if left untreated. Preterm delivery can result in complications for the mother and the baby, including respiratory distress syndrome, cerebral palsy, and long-term developmental problems. Tocolytic agents work by inhibiting or reducing uterine contractions, thereby delaying the onset of preterm labor. Various types of tocolytic agents are available, including beta-adrenergic agonists, calcium channel blockers, prostaglandin inhibitors, and oxytocin receptor antagonists. The choice of tocolytic agent depends on various factors, such as gestational age, maternal and fetal conditions, and potential side effects. Tocolytic agents are typically used with other interventions, such as corticosteroids and antibiotics, to improve the outcomes of preterm labor and delivery.
The global tocolytic agents industry analysis report comprehensively analyzes the market with factors that either aid or impede market growth, such as its drivers, restraints, and opportunities. The research provides insight into the companies that operate in the tocolytic agents market and their efforts to position themselves as key players through expansion strategies and innovations. It also highlights recent developments that contribute to the tocolytic agents market growth. The research also analyzes the impact of the COVID-19 pandemic.
This research is valuable for businesses seeking insights into the market, customers, and competition. The research provides special insights into the segmentation, regions, market size & projection, revenue CAGRs, and other important information that may help clients make the right decisions. The report assembles data from market players and professionals across the industrial value chain. The study also incorporates qualitative and quantitative assessments from industry professionals. Secondary research, surveys and interviews, and statistical modeling are all used in our research to estimate market size and projection. Our reports deliver the most reliable market data because of our specialized research methods.
Tocolytic Agents Market Dynamics
Preterm labor is a significant problem worldwide, and its prevalence is increasing due to various factors, such as changes in lifestyle and a rise in maternal age. This has led to an increase in the demand for tocolytic agents to prevent preterm birth. Introducing new tocolytic agents with enhanced effectiveness and safety profiles has resulted in the growth of the tocolytic agents market. This has provided healthcare providers with broader options to manage preterm labor. Tocolytic agents are often combined with other interventions, such as corticosteroids and antibiotics, to improve the outcomes of preterm labor and delivery. This has led to an increase in the demand for combination therapies, which is fueling the tocolytic agents market growth. There is a growing awareness among healthcare providers and patients about the risks associated with preterm birth, which has increased the use of tocolytic agents to prevent preterm labor.
Moreover, the rising healthcare expenditure in developed and developing countries has increased the availability and accessibility of tocolytic agents, contributing to the growth of the tocolytic agents market. However, tocolytic agents can cause several adverse effects, including maternal cardiovascular effects, fetal side effects, and delayed delivery, restricting the growth of the tocolytic agents. Despite the availability of various tocolytic agents, their efficacy in preventing preterm birth remains limited, hindering the growth of the tocolytic agents market.
Tocolytic Agents Market Ecosystem
Tocolytic Agents Market, by Drug Class
Tocolytic Agents Market, by Route of Administration
Tocolytic Agents Market by Drug Class
[75675]
Prostaglandin inhibitors are highly effective in reducing the incidence of preterm labor and delaying delivery. They act quickly to inhibit uterine contractions and are thus widely preferred by healthcare providers. Prostaglandin inhibitors treat many indications, including threatened preterm labor, cervical ripening, and labor induction. This versatility has contributed to their dominance in the tocolytic agents market. Prostaglandin inhibitors have a well-established safety profile and are generally well-tolerated by patients. This has led to their widespread use in clinical practice. Prostaglandin inhibitors have been on the market for several years, and their established market presence has contributed to their dominance in the tocolytic agents market. There is a strong product pipeline for prostaglandin inhibitors, with several new drugs in development. This is likely to increase further the dominance of the prostaglandin Inhibitors segment in the tocolytic agents market.
The market segmentation sections provide the tocolytic agents market outlook regarding the demarcation of different consumer groups. Market segmentation is the split of an industry into subgroups depending on characteristics such as product, technology, services, end user, and other factors. Market segmentation data helps organizations understand the preferences and distinctive demands of different customer groups and implement targeted marketing strategies. This data additionally helps in identifying potential tocolytic agents market demand opportunities.
Tocolytic Agents Market by Region
There is a rise in the cases of preterm births in North America. This high prevalence has led to an increase in the demand for tocolytic agents in the region. According to the Centers for Disease Control and Prevention, in 2021, preterm birth affected about 1 of every 10 infants born in the U.S., accounting for 10.5% of all births. North America's well-developed healthcare infrastructure has contributed to the availability and accessibility of tocolytic agents in the region. This has enabled healthcare providers to effectively manage preterm labor and reduce the incidence of preterm birth. The governments in North America have implemented favorable policies to promote the use of tocolytic agents in the management of preterm labor. This has led to increased awareness among healthcare providers and patients, further driving the market's growth. The healthcare expenditure in North America is among the highest in the world, which has enabled patients to access high-quality healthcare services and medications, including tocolytic agents. Significant technological advancements in drug development in North America have led to the development of new tocolytic agents with improved efficacy and safety profiles. This is also expected to boost regional growth.
Based on the regions, the global tocolytic agents market is segmented into:
The industry's regional segmentation provides insights into geographic pockets in terms of tocolytic agents industry trends, market size, share, and growth rate. This information helps organizations assess potential growth opportunities in new regional markets, understand competitive threats, and develop localized sales and expansion strategies. This section also offers deeper insights into the regional and country-level tocolytic agents market overview.
Key Components of the Report
Tocolytic Agents Market Competitive Landscape
The market competitive landscape analysis is performed by gathering and evaluating data about the key competitors, industry trends, and market dynamics. It involves collecting and analyzing data on factors such as products, pricing, geographic reach, customer demographics, marketing tactics, and recent developments. Competitive landscape analysis can help organizations identify present or prospective opportunities and risks in the market.
Tocolytic Agents Market Strategic Developments
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Tocolytic agents are a class of medications that are used to prevent or treat premature labor or preterm delivery. Tocolytic agents work by inhibiting or reducing uterine contractions, thereby delaying the onset of preterm labor.
Asia Pacific can be considered as the key growth region due to the surge in knee walker industry trends in China, Japan, and the Indian subcontinent.
During the forecast period, the revenue CAGR of the global tocolytic agents market is estimated to be 5.3%.
One of the most prominent trends in the tocolytic agents industry is the development of new tocolytic agents with improved efficacy and safety profiles.
Different adverse effects associated with tocolytic agents and limited efficacy of tocolytic agents are some of the restricting factors of the tocolytic agents market.
Many market players are entering into partnerships and collaborations with other companies, research institutions, and healthcare organizations to develop and commercialize new tocolytic agents.
The growing incidences of preterm labor and advancements in drug development are some of the major driving factors of the tocolytic agents market.
The prominent players operating in the global tocolytic agents market are Fresenius Kabi AG, Cardinal Health, Inc., Baxter, Pfizer Inc., and Merck & Co., Inc.
The prostaglandin inhibitors segment dominated the global tocolytic agents ma
*Insights on financial performance are subject to the availability of information in the public domain